ACHV Reports $12.3M Q4 Revenue, $0.08 EPS, FDA Accepts NDA, Partners with Adare for Cytisinicline Manufacturing, Launches $50M Buyback
Achieve Life Sciences, Inc. · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $5.30
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS